INDO US BIO-TECH | JK AGRI GENETICS | INDO US BIO-TECH/ JK AGRI GENETICS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 42.3 | -19.5 | - | View Chart |
P/BV | x | 8.6 | 1.5 | 595.6% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
INDO US BIO-TECH JK AGRI GENETICS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO US BIO-TECH Mar-23 |
JK AGRI GENETICS Mar-23 |
INDO US BIO-TECH/ JK AGRI GENETICS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 125 | 823 | 15.2% | |
Low | Rs | 25 | 352 | 7.1% | |
Sales per share (Unadj.) | Rs | 61.6 | 433.0 | 14.2% | |
Earnings per share (Unadj.) | Rs | 7.2 | -23.3 | -31.0% | |
Cash flow per share (Unadj.) | Rs | 8.0 | -18.0 | -44.7% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 54.3 | 281.6 | 19.3% | |
Shares outstanding (eoy) | m | 10.03 | 4.64 | 216.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.2 | 1.4 | 90.1% | |
Avg P/E ratio | x | 10.4 | -25.2 | -41.3% | |
P/CF ratio (eoy) | x | 9.4 | -32.7 | -28.6% | |
Price / Book Value ratio | x | 1.4 | 2.1 | 66.4% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 754 | 2,724 | 27.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 13 | 341 | 3.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 617 | 2,009 | 30.7% | |
Other income | Rs m | 0 | 26 | 0.8% | |
Total revenues | Rs m | 618 | 2,035 | 30.4% | |
Gross profit | Rs m | 94 | -84 | -112.2% | |
Depreciation | Rs m | 8 | 25 | 33.6% | |
Interest | Rs m | 12 | 70 | 17.1% | |
Profit before tax | Rs m | 74 | -153 | -48.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1 | -45 | -3.3% | |
Profit after tax | Rs m | 72 | -108 | -67.0% | |
Gross profit margin | % | 15.2 | -4.2 | -365.2% | |
Effective tax rate | % | 2.0 | 29.3 | 6.8% | |
Net profit margin | % | 11.7 | -5.4 | -218.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 599 | 2,978 | 20.1% | |
Current liabilities | Rs m | 123 | 2,138 | 5.8% | |
Net working cap to sales | % | 77.1 | 41.8 | 184.4% | |
Current ratio | x | 4.9 | 1.4 | 349.8% | |
Inventory Days | Days | 1 | 93 | 1.5% | |
Debtors Days | Days | 146,261,410 | 1,269 | 11,522,891.6% | |
Net fixed assets | Rs m | 90 | 396 | 22.6% | |
Share capital | Rs m | 100 | 46 | 216.2% | |
"Free" reserves | Rs m | 445 | 1,260 | 35.3% | |
Net worth | Rs m | 545 | 1,306 | 41.7% | |
Long term debt | Rs m | 17 | 112 | 15.2% | |
Total assets | Rs m | 689 | 3,375 | 20.4% | |
Interest coverage | x | 7.2 | -1.2 | -607.6% | |
Debt to equity ratio | x | 0 | 0.1 | 36.6% | |
Sales to assets ratio | x | 0.9 | 0.6 | 150.6% | |
Return on assets | % | 12.3 | -1.1 | -1,093.7% | |
Return on equity | % | 13.3 | -8.3 | -160.7% | |
Return on capital | % | 15.3 | -5.8 | -262.4% | |
Exports to sales | % | 0 | 3.4 | 0.0% | |
Imports to sales | % | 0 | 2.1 | 0.0% | |
Exports (fob) | Rs m | NA | 69 | 0.0% | |
Imports (cif) | Rs m | NA | 41 | 0.0% | |
Fx inflow | Rs m | 0 | 69 | 0.0% | |
Fx outflow | Rs m | 0 | 41 | 0.0% | |
Net fx | Rs m | 0 | 28 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 5 | 126 | 4.2% | |
From Investments | Rs m | -67 | -397 | 16.8% | |
From Financial Activity | Rs m | 63 | 12 | 513.4% | |
Net Cashflow | Rs m | 1 | -258 | -0.5% |
Indian Promoters | % | 70.2 | 73.1 | 96.0% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.8 | 26.9 | 110.9% | |
Shareholders | 1,166 | 7,347 | 15.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO US BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO US BIO-TECH | JK AGRI GENETICS |
---|---|---|
1-Day | 8.77% | 1.65% |
1-Month | 26.17% | 7.35% |
1-Year | 113.64% | 1.35% |
3-Year CAGR | 152.58% | -11.83% |
5-Year CAGR | 42.16% | -12.00% |
* Compound Annual Growth Rate
Here are more details on the INDO US BIO-TECH share price and the JK AGRI GENETICS share price.
Moving on to shareholding structures...
The promoters of INDO US BIO-TECH hold a 70.2% stake in the company. In case of JK AGRI GENETICS the stake stands at 73.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO US BIO-TECH and the shareholding pattern of JK AGRI GENETICS.
Finally, a word on dividends...
In the most recent financial year, INDO US BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
JK AGRI GENETICS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of INDO US BIO-TECH, and the dividend history of JK AGRI GENETICS.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.